Press Release NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC Jul 30
Press Release Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565 Jul 27